Optics News

Quarantines imposed during the COVID-19 pandemic were a risk factor for the progression and incidence of myopia in school-age children in China, according to a study published in Ophthalmology.

In a company release, Horizon Therapeutics announced results from a phase 2/3 trial demonstrating that its B-cell-depleting agent Uplizna reduced the severity of attacks in people with neuromyelitis optica spectrum disorder.

EyeQue’s MyReaderNumber provides personalized measurements for near and mid-distance vision via augmented reality technology in a smartphone app.

Visual impairment after a stroke is common. About two-thirds of stoke survivors have visual field loss in half of their field of vision, according to Rowe and colleagues.

A bipartisan group of U.S. House of Representatives members wrote to the CDC asking about the agency’s efforts to encourage early detection and prevention of childhood myopia.

Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein-antibody associated disease incur significant costs for individuals, their families and for society, according to study results published in Neurology.

Individuals with myopia, particularly high myopia, were found to be at greater risk of developing open-angle glaucoma, according to data published in the American Journal of Ophthalmology.

Short-term peripheral myopic defocus significantly inhibited axial elongation in adults, according to a study published in Scientific Reports.

BOSTON – The pH of the recently approved Vuity from Allergan, an Abbvie company, improves the drug’s availability and translates to faster pupil size reduction, according to a presentation here at the American Academy of Optometry annual meeting.

Patients with multiple sclerosis were found to have alterations in binocular vision, particularly if optic neuritis was present, according to a study published in Clinical Optometry.